DAICW experienced a dramatic operational collapse with revenue nearly disappearing while cash position deteriorated severely and working capital turned deeply negative.
The company's core business appears to have essentially shut down, with revenue collapsing to minimal levels and accounts receivable similarly evaporating, suggesting either a major customer loss or operational cessation. The dramatic shift from positive working capital to a $5.4 million deficit, combined with cash declining from $6.5 million to $1.4 million, creates immediate liquidity concerns despite recent equity raises.
The financial picture reveals a company in severe distress, with revenue collapsing from $778K to just $12K and gross profit similarly devastated. While the company increased R&D spending meaningfully, this was overwhelmed by the operational breakdown evidenced by accounts receivable falling from $3.6M to $102K. The balance sheet deteriorated significantly with current liabilities exceeding current assets by over $5 million, creating urgent funding needs despite recent SEC-registered equity offerings.
Revenue declined 98.4% — significant demand weakness or market share loss warrants investigation.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Inventory surged 62.4% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
R&D investment increased 53.9% — signals commitment to future product development, though near-term margin impact.
Current assets declined 42.5% — monitor working capital adequacy and short-term liquidity.
Total assets contracted 27.3% — asset sales, write-downs, or balance sheet optimization underway.
Current liabilities rose 17% — increased short-term obligations, watch current ratio.
Liabilities increased 13.5% — monitor debt-to-equity ratio and interest coverage.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →